Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study

SIMPLE SUMMARY: The identification of clinical and tumor factors to identify patients who most benefit from oncological treatments is a crucial clinical unmet need. We studied differences in the tumor microenvironment assessed using an easy method called immunohistochemistry between cancers in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebuzzi, Sara Elena, Brunelli, Matteo, Galuppini, Francesca, Vellone, Valerio Gaetano, Signori, Alessio, Catalano, Fabio, Damassi, Alessandra, Gaggero, Gabriele, Rescigno, Pasquale, Maruzzo, Marco, Merler, Sara, Vignani, Francesca, Cavo, Alessia, Basso, Umberto, Milella, Michele, Panepinto, Olimpia, Mencoboni, Manlio, Sbaraglia, Marta, Dei Tos, Angelo Paolo, Murianni, Veronica, Cremante, Malvina, Llaja Obispo, Miguel Angel, Maffezzoli, Michele, Banna, Giuseppe Luigi, Buti, Sebastiano, Fornarini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136746/
https://www.ncbi.nlm.nih.gov/pubmed/37190322
http://dx.doi.org/10.3390/cancers15082394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136746/
https://www.ncbi.nlm.nih.gov/pubmed/37190322
http://dx.doi.org/10.3390/cancers15082394

Ejemplares similares